BioCentury | Apr 11, 2019
Company News

Management tracks: Prime, Flexion, NodThera, Imara

...the clinical and genomic data analytics company's first president. Dvorak was president and CEO of Zimmer...
BioCentury | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

...Robert Marshall Jr. as CFO, effective Sept. 24. He was VP of Americas finance at Zimmer...
BioCentury | Nov 22, 2017
Company News

Management tracks: Biogen, Neurocrine

...Biosciences Inc. (NASDAQ:NBIX) hired Matt Abernethy as CFO. He was VP of investor relations at Zimmer...
BioCentury | Jul 17, 2017
Company News

Management tracks

...will become president and CSO. Londy was COO at Accuray Inc. (Sunnyvale, Calif.). Musculoskeletal company Zimmer...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...raised less than $300 million. In the U.S., three raised more than $800 million, with Zimmer...
...Ireland UCB S.A. (Euronext:UCB), Brussels, Belgium U.S. Food and Drug Administration (FDA), Silver Spring, Md. Zimmer...
BioCentury | Dec 9, 2016
Financial News

Zimmer Biomet completes private placement of senior notes

...Nikko Capital Markets and others were underwriters. Zimmer Biomet Holdings Inc. (NYSE:ZBH; SIX:ZBH), Warsaw, Ind. Alex Himes Zimmer...
BioCentury | Aug 15, 2016
Finance

Serving returns

...Medtech in December when it purchased $15 million of convertible bonds and warrants. In July, Zimmer...
...$55.26), or about $132 million. Ally Bridge paid €30.10 for each bond and warrant, and Zimmer...
...Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. U.S. Food and Drug Administration (FDA) , Silver Spring, Md. Zimmer...
BioCentury | Apr 14, 2016
Distillery Therapeutics

Therapeutics: Liver X receptor (LXR)

...X receptor (LXR) LICENSING STATUS: Unpatented; licensing status not applicable; available for partnering PUBLICATION DETAILS: Zimmer...
BioCentury | Aug 17, 2015
Company News

Biomet, Zimmer deal

...to Zimmer Biomet Holdings Inc. (see BioCentury, May 5, 2014). Biomet Inc. , Warsaw, Ind. Zimmer Holdings Inc....
BioCentury | Aug 11, 2014
Strategy

Profusion of exclusions

...acid derivatives (osteoarthritis) Euflexxa sodium hyaluronate Ferring Pharmaceuticals A/S ü Gel-One cross-linked hyaluronate Seikagaku Corp. (Tokyo:4548)/Zimmer Holdings Inc....
Items per page:
1 - 10 of 39
BioCentury | Apr 11, 2019
Company News

Management tracks: Prime, Flexion, NodThera, Imara

...the clinical and genomic data analytics company's first president. Dvorak was president and CEO of Zimmer...
BioCentury | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

...Robert Marshall Jr. as CFO, effective Sept. 24. He was VP of Americas finance at Zimmer...
BioCentury | Nov 22, 2017
Company News

Management tracks: Biogen, Neurocrine

...Biosciences Inc. (NASDAQ:NBIX) hired Matt Abernethy as CFO. He was VP of investor relations at Zimmer...
BioCentury | Jul 17, 2017
Company News

Management tracks

...will become president and CSO. Londy was COO at Accuray Inc. (Sunnyvale, Calif.). Musculoskeletal company Zimmer...
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...raised less than $300 million. In the U.S., three raised more than $800 million, with Zimmer...
...Ireland UCB S.A. (Euronext:UCB), Brussels, Belgium U.S. Food and Drug Administration (FDA), Silver Spring, Md. Zimmer...
BioCentury | Dec 9, 2016
Financial News

Zimmer Biomet completes private placement of senior notes

...Nikko Capital Markets and others were underwriters. Zimmer Biomet Holdings Inc. (NYSE:ZBH; SIX:ZBH), Warsaw, Ind. Alex Himes Zimmer...
BioCentury | Aug 15, 2016
Finance

Serving returns

...Medtech in December when it purchased $15 million of convertible bonds and warrants. In July, Zimmer...
...$55.26), or about $132 million. Ally Bridge paid €30.10 for each bond and warrant, and Zimmer...
...Tesaro Inc. (NASDAQ:TSRO), Waltham, Mass. U.S. Food and Drug Administration (FDA) , Silver Spring, Md. Zimmer...
BioCentury | Apr 14, 2016
Distillery Therapeutics

Therapeutics: Liver X receptor (LXR)

...X receptor (LXR) LICENSING STATUS: Unpatented; licensing status not applicable; available for partnering PUBLICATION DETAILS: Zimmer...
BioCentury | Aug 17, 2015
Company News

Biomet, Zimmer deal

...to Zimmer Biomet Holdings Inc. (see BioCentury, May 5, 2014). Biomet Inc. , Warsaw, Ind. Zimmer Holdings Inc....
BioCentury | Aug 11, 2014
Strategy

Profusion of exclusions

...acid derivatives (osteoarthritis) Euflexxa sodium hyaluronate Ferring Pharmaceuticals A/S ü Gel-One cross-linked hyaluronate Seikagaku Corp. (Tokyo:4548)/Zimmer Holdings Inc....
Items per page:
1 - 10 of 39